Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07519317) titled 'Dosing and Deployment Trial: A Home-based Optokinetic Treatment' on April 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Outcomes Assessor).
Primary Sponsor: Duke University
Condition:
Spatial Neglect
Intervention:
Behavioral: Optokinetic stimulation
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 1, 2026
Target Sample Size: 100
To know more, visit https://clinicaltrials.gov/study/NCT07519317
Published by HT Digital Content Services with permission from Health D...